Abstract
Epstein-Barr virus (EBV) is a ubiquitous member of the human herpesvirus group. The virus is the agent of infectious mononucleosis (IM) and shows the peculiar capability of immortalizing human B lymphocytes in vivo and in vitro; EBV is also associated with the development of African Burkitt’s lymphoma (BL), undifferentiated nasopharyngeal carcinoma (NPC), and lymphoproliferative disorders and lymphomas in individuals with severe congenital or acquired immunodeficiencies.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
REFERENCES
Liebowitz, D., and Kieff, E., 1993, Epstein-Barr virus, in: The Human Herpesviruses( B. Roizman, R. J. Whithly, and C. Lopez, eds.), Raven Press, New York, pp. 107–172.
Jondal, M., and Klein, G., 1973, Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes, J. Exp. Med. 138: 1365–1378.
Sixbey, J. W., Nedrud, J. G., Raab-Traub, N., Hanes, R. A., and Pagano, J. S., 1984, Epstein-Barr virus replication in oropharyngeal epithelial cells, N. Engl, J. Med.310: 1225–1230.
Jondal, M., Klein, G., Oldstone, M. B. A., Bokish, V., and Yefenof, E., 1976, An association between complement and Epstein-Barr virus receptors on human lymphoid cells, Scand. J. Immunol. 5: 401–410.
Miller, G., 1990, Epstein-Barr virus. Biology, pathogenesis, and medical aspects, in: Virology, 2nd Ed., Raven Press, New York, pp. 1921–1958.
Niederman, J., Miller, G., Pearson, H., and Pagano, J., 1976, Pattern of excretion of Epstein-Barr virus in saliva and other oropharyngeal sites during infectious mononucleosis, N. Engl. J. Med. 294: 1355–1359.
Lenoir, G. M., 1986, Role of the virus, chromosomal translocation and cellular oncogenes in the aetiology of Burkitt’s lymphoma, in: The Epstein-Barr Virus: Recent Advances( M. A. Epstein and B. G. Achong, eds.), Wiley, New York, pp. 183–205.
Purtilo, D. T., 1983, Immunopathology of X-linked lymphoproliferative syndrome, Immunol. Today 4: 291–297.
Ernberg, I., and Altiok, E., 1989, The role of Epstein-Barr virus in lymphomas of HIV carriers. APMIS (Suppl.) 8: 63–66.
Greenspan,J. S., Greenspan, D., Lennette, E. T, Abrams, D. L., Conant, M. A., Petersen, V., and Freese, K., 1985, Replication of Epstein-Barr virus within the epithelial cells of oral “hairy” leukoplakia, an AIDS-associated lesion, N. Engl, J. Med. 313: 1564–1571.
Catalano, M. O., Carson, D. A., Niederman,J. C, Feorino, P., and Vaughan, J. H.51980, Antibody to the rheumatoid arthritis nuclear antigen: Its relationship to in vivo Epstein-Barr virus infection, J. Clin. Invest. 65:1238–1242.
Alspaugh, M. A., Henle, G., Lennette, E. T, and Henle, W, 1981, Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis, J. Clin. Invest. 67: 1134–1140.
Billings, P. B., Hoch, S. O., and Vaughan, J. H., 1984, Polymorphism of the EBNA-RANA antigen in Epstein-Barr virus positive cell lines, Arthritis Rheum. 27: 1423–1427.
Tosato, G., Steinberg, A. D., Yarchoan, R., Heliman, C. A., Pike, S. E., DeSeau, V., and Blaese, R. M., 1984, Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis, J. Clin. Invest. 73: 1789–1795.
Slaughter, L., Carson, D. A., Jensen, F. J., Holbrook, T. L., and Vaughan, J. H., 1978, In vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects, J. Exp. Med. 148: 1429–1434.
Burastero, S. E., Casali, P., Wilder, R. L., and Notkins, A. L., 1988, Mono-reactive high affinity and polyreactive low affinity rheumatoid factors are produced by CD5 + B cells from patients with rheumatoid arthritis, J. Exp. Med. 168: 1979–1992.
Rhodes, G., Carson,D.A.,ValbrechtJ.,Houghten, R., andVaughanJ. H., 1985, Human immune responses to synthetic peptides from the Epstein-Barr nuclear antigen, J. Immunol. 134: 211–216.
LukaJ., Kreofsky, T., Pearson, G. R., Hennessy, K, and Kieff, E., 1984, Identification and characterization of a cellular protein that cross-reacts with the Epstein-Barr virus nuclear antigen, J. Virol. 52: 833–838.
Fox, R. I., Sportsman, R., Rhodes, G. H., Luka,J., Pearson, G., and Vaughan,J. H., 1986, Rheumatoid arthritis synovial membrane contains a 62 kd protein that shares an antigenic epitope with the Epstein-Barr virus encoded EBNA-1 antigen, J. Clin. Invest. 77: 1539–1547.
Roudier, J., Rhodes, G. H., Vaughan, J. H., and Carson, D. A., 1988, The Epstein-Barr virus glycoprotein gpllO, a molecular link between HI A DR4, HLA DR1 and rheumatoid arthritic, Scand. J. Immunol. 27: 367–371.
Gregersen, P. K., Silver, J., and Winchester, R. J., 1987, Shared epitope hypothesis, Arthritis Rheum. 30: 1205–1213.
Klareskog, L., Forsum, U., Scheynius, A., Kabelitz, D., and Wigzell, H., 1982, Evidence in support of a self-perpetuating HLA-DR dependent delayed type cell reaction in rheumatoid arthritis, Proc. Natl. Acad. Sci. U.S.A. 79: 3632–3636.
Fox, R. I., Luppi, M., Pisa, P., and Kang, H.-I., 1992, Potential role of Epstein-Barr virus in Sjögren’s syndrome and rheumatoid arthritis, J. Rheumatol (Suppl 19) 32: 18–24.
Akobashi, I., Jamamoto, J., Katsuki, T, and Matsuda, I., 1983, Unique pattern of EBV specific antibodies in recurrent parotitis, Lancet 2: 1049–1090.
Fox, R. I., Pearson, G., and Vaughan, J. H., 1986, Detection of Epstein-Barr virus associated antigens and DNA in salivary gland biopsies from patients with Sjögren’s syndrome, J. Immunol. 137: 3162–3168.
Saito, I., Compton, S. B., and Fox, R. I., 1989, Detection of Epstein-Barr virus by DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjögren’s syndrome, J. Exp. Med.169: 191–198.
Lerner, M. R., Andrews, N. C, Miller, G., and Steitz, J. A., 1981, Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus, Proc. Natl. Acad. Sci. U.S.A. 78: 805–809.
Inoue, N., Harada, S., Miyasaka, N., Oya, A., and Yanagi, IL, 1991, Analysis of antibody titers to Epstein-Barr virus nuclear antigens in sera of patients with Sjogren’s syndrome and with rheumatoid arthritis, J. Infect. Dis. 164: 22–28.
Tsokos, G. C, and Balow, J. E., 1984, Cellular immune responses in systemic lupus erythematosus, Prog. Allergy 35: 93–161.
Nakamura, M., Burastero, S. E., Ueki, Y, Larrick, J. W., Notkins, A. L., and Casali, P., 1988, Probing the normal and autoimmune B cell repertoire with EBV. Frequency of B cells producing monoreactive high affinity autoantibodies in patients with Hashimoto disease and SLE, J. Immunol. 141: 4165–4172.
Sabbatini, A., Bombardieri, S., and Migliorini, P., 1993, Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I, Eur. J. Immunol 23: 1146–1152.
Marchini, B., Dolcher, M. P., Sabbatini, A., Klein, G., and Migliorini, P., 1994, Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases, J. Autoimmun. 7: 179–191.
Incaprera, M., Bazzichi, A., Manunta, M., Chapman, C. J., Stevenson, P. K., and Garzelli, C, 1993, Epitope homology between Epstein-Barr virus nuclear antigen-2 (EBNA-2) and systemic lupus autoantigens, in: Proceedings of International Symposium, The Impact of Biotechnology on Autoimmunity, Florence, Italy, 1993, Biotec 8: 106.
Costa, O., and Monier, J. C, 1986, Antihistone antibodies detected by ELISA and immunoblotting in systemic lupus erythematosus and rheumatoid arthritis, J. Rheumatol. 13: 722–725.
Shoenfeld, Y, and Segol, O., 1989, Anti-histone antibodies in SLE and other autoimmune diseases, Clin. Exp. Rheumatol. 7: 265–271.
Vainio, E., Lenoir, G. M., and Franklin, R. M., 1983, Autoantibodies in three populations of Burkitt’s lymphoma patients, Clin. Exp. Immunol. 54: 387–396.
Garzelli, C, Incaprera, M., Bazzichi, A., Manunta, M., Rognini, F., and Falcone, G., 1994, Epstein-Barr virus-transformed human B lymphocytes produce natural antibodies to histones, Immunol. Lett. 39: 277–282.
Garzelli, C, Incaprera, M., Bazzichi, A., Manunta, M., and Falcone, G., 1995, Relationship of an idiotype expressed on a polyreactive monoclonal autoantibody induced by Epstein-Barr virus to anti-histone antibodies, Immunol. Infect. Dis. 5: 53–58.
Taub, J. W., Warner, I., Holtkamp, C, Beardsley, D. S., and Lusher, J. M., 1995, Characterization of autoantibodies against the platelet glycoprotein antigens Ilb/IIIa in childhood idiopathic thrombocytopenia purpura, Am. J. Hematol. 48: 104–107.
Xie, K., and Snyder, M., 1995, Two short autoepitopes on the nuclear dot antigen are similar to epitopes encoded by the Epstein-Barr virus, Proc. Natl. Acad. Sci. U.S.A. 92: 1639–1643.
Grose, C, Henle, W., Henle, G., and Feorino, R M., 1975, Primary Epstein-Barr virus infection in acute neurologic diseases, N. Engl. J. Med. 292: 392–395.
Weinstein, M., 1991, Epstein-Barr virus and neurologic disease, Neurol. Res. 13: 199–200.
Bray, P. F., Culp, K. W, McFarlin, D. E., Panitch, H. S., Torkelson, R. D., and Schlight, J. P., 1992, Demyelinating disease after neurologically complicated primary Epstein-Barr virus infection, Neurology 42: 278–282.
Tsutsumi, H., Kamazaki, H., Nakata, S., Nagao, M., Chiba, S., Imai, S., and Osato, T, 1994, Sequential development of acute meningoencephalitis and transverse myelitis caused by Epstein-Barr virus during infectious mononucleosis, Pediatr. Infect. Dis. J. 13: 665–667.
Ito, H., Sayama, S., Irie, S., Kanazawa, N., Saito, T, Kowa, H., Haga, S., and Ikeda, K., 1994, Antineuronal antibodies in acute cerebellar ataxia following Epstein-Barr virus infection, Neurology 44: 1506–1507.
Lindberg, C, Andersen, O., Vahlne, A., Dalton, M., and Renmarker, B., 1991, Epidemiological investigation of the association between infectious mononucleosis and multiple sclerosis, Neuroepidemiology 10: 62–65.
Martyn, C. N., Cruddas, M., and Compston, D. A. S., 1993, Symptomatic Epstein-Barr virus infection and multiple sclerosis, J. Neurol. Neurosurg. Psychiatry 56: 167–168.
Haahr, S., Sommerlund, S., Moller-Larsen, A., Mogensen, S., and Andersen, H. M. K., 1992, Is multiple sclerosis caused by a dual infection with retrovirus and Epstein-Barr virus? Neuroepidemiology 11: 299–303.
Sumaya, C. V., Myers, L. W., and Ellison, G. W., 1980, Epstein-Barr virus antibodies in multiple sclerosis, Arch. Neurol. 37: 94–96.
Bray, P. F., Bloomer, L. C, Salmon, V. C, Bagley, M. H., and Larsen, P. D., 1983, Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis, Arch. Neurol. 40: 406–408.
Larsen, P. D., Bloomer, L. C, and Bray, P. F., 1985, Epstein-Barr virus nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis, Neurology 35: 435–438.
Sommerlund, M., Pallesen, G., Moller-Larsen, A., Hansen, H. J., and Haahr, S., 1993, Retrovirus-like particles in an Epstein-Barr virus-producing cell line derived from a patient with chronic progressive myelopathy, Acta Neurol. Scand. 87: 71–76.
Bray, P. F., Luka,J., Bray, P. F., Culp, K. W., and Schlight, J. P., 1992, Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis, CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein, Neurology 42: 1798–1804.
Holborow, E. J., Hemsted, E. H., and Mead, S. V., 1973, Smooth muscle autoantibodies in infectious mononucleosis, Br. Med. J. 3: 323–325.
Sutton, R. N. P., Emond, R. T. D., Thomas, D. B., and Doniach, D., 1974, The occurrence of autoantibodies in infectious mononucleosis, Clin. Exp. Immunol 17: 427–436.
Andersen, P., and Faber, V., 1978, Antibodies to smooth muscle and other tissue components in infectious mononucleosis, Scand. J. Infect. Dis. 10: 1–5.
Mead, G. M., Cowin, P., and Whitehouse, J. M. A., 1980, An ti tubulin antibody in healthy adults and patients with infectious mononucleosis and its relationship to smooth muscle antibody (SMA), Clin. Exp. Immunol. 39: 328–336.
Garzelli, C, Pacciardi, A., Basolo, F., and Falcone, G., 1989, Mechanisms other than polyclonal B cell activation possibly involved in Epstein-Barr virus-induced autoimmunity, Clin. Exp. Immunol. 76: 412–416.
Linder, E., Kurki, P., and Andersson, L. C, 1979, Autoantibody to “intermediate filaments” in infectious mononucleosis, Clin. Immunol. Immunopathol 14: 411–417.
Kataaha, P. EL, Mortazavi-Milani, S. M., Rüssel, G., and Holborow, E. J., 1985, Anti-intermediate filaments antibodies, antikeratin antibody, and antiperinuclear factor in rheumatoid arthritis and infectious mononucleosis, Ann. Rheum. Dis. 44: 446–449.
Thomas, D. B., 1972, Antibodies to membrane antigen common to thymocytes and a subpopulation of lymphocytes in infectious mononucleosis sera, Lancet i:399–403.
Misra, R., Venables, P.J. W., Plater-Zyberk, C, and Watkins, P. R, 1989, Anti-cardiolipin antibodies in infectious mononucleosis react with the membrane of activated lymphocytes, Clin. Exp. Immunol. 75: 35–40.
Garzelli, C, Manunta, M., Incaprera, M.., Bazzichi, A. Conaldi, P. G., and Falcone, G., 1992, Antibodies to histones in infectious mononucleosis, Immunol. Lett. 32: 111–116.
Holborow, E. J., Asherson, G. L.,Johnson, G. D., Barnes, R. D. S., and Carmichael, D. L., 1963, Antinuclear factor and other antibodies in blood and liver diseases, Br. Med. J. 1: 656–658.
Wollheim, F. A., and Williams, R. C, 1966, Studies on the macroglobulins of human serum. I. Polyclonal immunoglobulin class M (IgM) increases in infectious mononucleosis, N. Engl.]. Med. 274: 61–67.
Jenkins, W. J., Koster, H. G., Marsh, W. L., and Carter, R. L., 1965, Infectious mononucleosis: An unsuspected source of anti-i, Br. J. Haematol 11: 480–483.
Rosenfield, R. E., Schmidt, P. J., Calvo, R. C, and McGinniss, R. L., 1965, Anti-i, a frequent cold agglutinin in infectious mononucleosis, Vox Sang. 10: 631–634.
Troxel, D. B., Innella, F., and Cohen, R. J., 1966, Infectious mononucleosis complicated by hemolytic anemia due to anti-i, Am. J. Pathol. 46: 625–631.
Ritter, K., Brestrich, H., Nellen, B., Kratzin, H., Eiffert, H., and Thomssen, R., 1990, Autoantibodies against triosephosphate isomerase. A possible clue to pathogenesis of hemolytic anemia in infectious mononucleosis, ]. Exp. Med. 171: 565–570.
Geurs, F., Ritter, K, Mast, A., and Van Meale, V., 1992, Successful plasmapheresis in corticosteroid-resistant hemolysis in infectious mononucleosis: Role of autoantibodies against triosephosphate isomerase, Acta Haematol 88: 142–146.
Ritter, K, Kühl, R.-J., Semrau, F., Eiffert, H. D., Kratzin, H., and Thomssen, R., 1994, Manganese superoxide dismutase as a target of autoantibodies in acute Epstein-Barr virus infection, J. Exp. Med. 180: 1995–1998.
Fong, S., Vaughan, J. H., Tsoukas, C. D., and Carson, D. A., 1982, Selective induction of autoantibody secretion in human bone marrow by Epstein-Barr virus, J. Immunol. 129: 1941–1945.
Garzelli, C, Taub, F. E., ScharffJ. E., Prabhakar, B. S., Ginsberg-Fellner, F., and Notkins, A. L., 1984, Epstein-Barr virus-transformed lymphocyte produce monoclonal antibodies that react with antigens in multiple organs,]. Virol. 52: 722–725.
Robinson, J. E., and Stevens, K. C, 1984, Production of autoantibodies to cellular antigens by human B cells transformed by Epstein-Barr virus, Clin. Immunol. Immunopathol. 33: 339–350.
Garzelli, C, Taub, E E.Jenkins, M. C, Drell, D. W., Ginsberg-Fellner, E, and Notkins, A. L., 1986, Human monoclonal autoantibodies that react with both pancreatic islets and thyroid, J. Clin. Invest. 77: 1627–1631.
Taub, F., Satoh, J., Garzelli, C, Essani, K., and Notkins, A. L., 1985, Human monoclonal autoantibodies reactive with multiple organs, in: Human Hybridomas and Monoclonal Antibodies(E. G. Engleman, S. K. H. Foung,J. Larrick, and A. Raubitchek, eds.), Plenum Press, New York, pp. 263–275.
Casali, P., and Notkins, A. L., 1989, Probing thehuman B-cell repertoire with EBV: Polyreactive antibodies and CD5+ lymphocytes, Annu. Rev. Immunol. 7: 513–535.
Rhodes, G., Rumpold, H., Kurki, P., Patrick, K. M., Carson, D. A, and Vaughan, J. H., 1987, Autoantibodies in infectious mononucleosis have specificity for the glycine-alanine repeating region of the Epstein-Barr virus nuclear antigen, J. Exp. Med. 165:1026–1040.
Garzelli, C, Pacciardi, A., Carmignani, M., Conaldi, P. G., Basólo, F., and Falcone, G., 1989, A human monoclonal autoantibody isolated from a patient with infectious mononucleosis reactive with both self antigens and Epstein-Barr nuclear antigen (EBNA), Immunol. Lett. 22: 211–216.
Garzelli, C, Incaprera, M., Bazzichi, A., and Falcone, G., 1992, Detection of an idiotope on a human monoclonal autoantibody by monoclonal anti-idiotypic antibody and its relationship to Epstein-Barr virus-induced autoimmunity, Autoimmunity 11: 171–177.
Nakamura, M., Burastero, S. E., Notkins, A. L., and Casali, P., 1988, Human monoclonal rheumatoid factor-like antibodies from CD5 (Leu-1) + B cells are polyreactive, J. Immunol. 140: 4180–4186.
Schwartz, R. S., 1988, Polyvalent anti-DNA autoantibodies: Immunochemical and biological significance, Int. Rev. Immunol. 3: 97–115.
Sanz, I., Dang, H., Takei, M., Talal, N., and Capra, D., 1989, VH sequence of a human anti-Sm autoantibody. Evidence that autoantibodies can be unmutated copies of germ-line genes, J. Immunol. 142: 883–887.
Pasqual, V., Victor, K., Lelsz, D., Spellerberg, M. B., Hamblin, T. J., Thompson, K. M., Randen, I., Natvig, J., Capra, J. D., and Stevenson, F. K., 1991, Nucleotide sequence analysis of the V regions of two IgM cold agglutinins. Evidence that VH4-21 gene segment is responsible for the major cross-reactive idiotype, J. Immunol. 146: 4385–4391.
Chapman, C. J., Spellerber, M. B., Smith, G. A., Carter, S. J., Hamblin, T. J., and Stevenson, F. K., 1993, Autoanti-red cell antibodies synthesized by patients with infectious mononucleosis utilize the VH4-21 gene segment, J. Immunol. 151: 1051–1061.
Vaughan, J. H., Valbracht, J. R., Nguyen, M.-D., Handley, H. H., Smith, R. S., Patrick, K., and Rhodes, G. H., 1995, Epstein-Barr virus induced autoimmune responses. I. Immunoglobulin M autoantibodies to proteins mimicking and non mimicking Epstein-Barr virus nuclear antigen-1, J. Clin. Invest. 95: 1306–1315.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Plenum Press, New York
About this chapter
Cite this chapter
Garzelli, C. (1996). Epstein-Barr Virus and Autoimmunity. In: Friedman, H., Rose, N.R., Bendinelli, M. (eds) Microorganisms and Autoimmune Diseases. Infectious Agents and Pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0347-3_9
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0347-3_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-45236-9
Online ISBN: 978-1-4613-0347-3
eBook Packages: Springer Book Archive